Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Pharma Equity Group - Video med præsentation af ny strategi for at accelerere vækst og skabe værdi for aktionærerne

By Claus ThestrupCEO, Sweden
Pharma Equity Group

Pharma Equity Group annoncerede den 28 maj en opdatering til deres strategi og kommercialiseringsplaner for at accelerere væksten og skabe værdi for aktionærerne.

Frigørelse af værdi på tværs af life science-sektoren
• Udvider investeringsfokus til også at omfatte MedTech og Digital Health
• Målretter en diversificeret portefølje inden for både Pharma og MedTech
• Muliggør porteføljediversificering på tværs af life science
• Afbalancerer investeringer med både kort og lang tidshorisont
• Skaber øget deal-momentum og nyhedsstrøm

Du kan se hele præsentationen med CEO Christian Tange her: PEG opdatering af strategi

Disclaimer: HC Andersen Capital modtager betaling fra Pharma Equity Group for en Digital IR abonnementsaftale. /Claus Thestrup kl. 8:15, 04/06/2025.

Pharma Equity Group develops medicines for the treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The Company uses repositioning of existing medicines and takes drug candidates to a clinical Phase III stage, after which they are handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the Company.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.